Heparin therapy as adjuvant treatment for profound idiopathic sudden sensorineural hearing loss.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

This study aimed to provide evidence of whether unfractionated heparin used as adjuvant therapy in conjunction with systemic corticosteroid therapy improves hearing recovery in patients with profound idiopathic sudden sensorineural hearing loss (ISSNHL), and to compare the effect of this treatment with those of additional intratympanic corticosteroid therapy.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Laryngoscope

Title: The Laryngoscope

Publisher: Wiley

ISSN (Electronic): 1531-4995

ISSN (Print): 0023-852X

Publication date (Electronic): May 2020

Volume: 130

Issue: 5

Affiliations

[1 ] Department of Otorhinolaryngology-Head and Neck Surgery, Gachon University Gil Medical Center, Incheon, Korea.

Article

DOI: 10.1002/lary.28231

PubMed ID: 31397902

SO-VID: f4321864-6927-46f6-8a50-be6066d226da

History

Keywords: Sudden hearing loss,combination drug therapy,heparin,steroids,treatment outcome

Data availability:

Keywords: Sudden hearing loss, combination drug therapy, heparin, steroids, treatment outcome

Comments

Comment on this article

scite_

Smart Citations

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

Cited by 3

See all cited by